SKI Market

Indian Indices

Nifty

22,419.95 -150.40
(-0.67%)

Sensex

73,730.16 -609.28
( -0.82%)

Bank Nifty

48,201.05 -293.90
( -0.61%)

Nifty IT

33,666.25 111.85
( 0.33%)

Global Indices

Nasdaq

15,611.76 -100.99
(-0.64%)

Dow Jones

38,085.80 -375.12
(-0.98%)

Hang Seng

17,651.15 366.61
(2.12%)

Nikkei 225

37,934.76 306.28
(0.81%)

Forex

USD-INR

83.31 0.00
(0.00%)

EUR-INR

89.11 0.15
(0.17%)

GBP-INR

103.70 0.42
(0.41%)

JPY-INR

0.54 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

J B Chemicals & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

506943

INE572A01036

172.9013781

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JBCHEPHARM

56.87

28791.74

EPS(TTM)

Face Value()

Div & Yield %

32.62

0.48

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	296.64	292.17	225.97	237.68	273.84	262.57
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	296.64	292.17	225.97	237.68	273.84	262.57
Other Income	14.28	1.73	1.87	4.03	2.04	2.33
Stock Adjustments	0.98	9.20	-2.26	-0.28	-0.40	-1.88
Total Income	311.90	303.10	225.58	241.43	275.48	263.02
EXPENDITURE :
Raw Materials	182.36	172.69	112.16	132.81	161.39	154.65
Power & Fuel Cost	18.58	20.00	17.75	18.13	19.43	21.28
Employee Cost	34.39	35.08	29.37	32.00	34.03	33.85
Other Manufacturing Expenses	15.44	13.05	8.91	8.96	10.62	13.45
Selling & Administrative Expenses	27.60	30.14	24.29	21.74	23.84	23.30
Miscellaneous Expenses	9.10	5.61	3.66	4.65	5.64	4.39
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	287.47	276.57	196.14	218.30	254.96	250.92
Operating Profit	24.43	26.53	29.44	23.13	20.52	12.10
Interest	3.64	3.20	4.47	6.14	7.65	9.42
Gross Profit	20.79	23.33	24.97	16.99	12.87	2.68
Depreciation	8.46	8.08	8.16	8.71	8.74	8.53
Profit Before Tax	12.33	15.25	16.81	8.28	4.13	-5.85
Tax	0.26	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.37	4.20	-2.86	0.00	0.00	0.00
Reported Net Profit	8.71	11.05	19.67	8.28	4.13	-5.85
Extraordinary Items	7.28	0.12	0.03	1.99	-1.12	0.70
Adjusted Net Profit	1.43	10.93	19.64	6.29	5.25	-6.55
Adjustment below Net Profit	0.25	0.28	0.36	-0.14	0.00	2.13
P & L Balance brought forward	58.46	47.79	27.76	18.92	14.79	18.51
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.80	0.66	0.00	-0.70	0.00	0.00
P & L Balance carried down	66.61	58.46	47.79	27.76	18.92	14.79
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	3.00	2.50	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.30	0.25	0.00	0.00	0.00
Earnings Per Share-Unit Curr	3.27	4.16	7.40	3.32	1.66	0.00
Earnings Per Share(Adj)-Unit Curr	3.27	4.16	7.40	3.32	1.66	0.00
Book Value-Unit Curr	50.30	47.28	43.01	36.23	32.97	31.08
Book Value(Adj)-Unit Curr	50.30	47.28	43.01	36.23	32.97	31.08

22,419.95 -150.40 (-0.67%)

73,730.16 -609.28 ( -0.82%)

48,201.05 -293.90 ( -0.61%)

33,666.25 111.85 ( 0.33%)

15,611.76 -100.99 (-0.64%)

38,085.80 -375.12 (-0.98%)

17,651.15 366.61 (2.12%)

37,934.76 306.28 (0.81%)

83.31 0.00 (0.00%)

89.11 0.15 (0.17%)

103.70 0.42 (0.41%)

0.54 0.00 (-0.15%)